title: Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B.
authors.affiliation: Dermatology Institute, Clalit Health Services, Southern Region, Beer Sheva, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Vardy
authors.forename: Y
authors.initials: Y
authors.lastname: Barenholz
authors.forename: N
authors.initials: N
authors.lastname: Naftoliev
authors.forename: S
authors.initials: S
authors.lastname: Klaus
authors.forename: L
authors.initials: L
authors.lastname: Gilead
authors.forename: S
authors.initials: S
authors.lastname: Frankenburg
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage*; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D000666:Amphotericin B